The EVAR Center

Filter Your Results

 

News

 

Endologix’s Ovation LUCY Study Completes Patient Enrollment

February 14, 2017 -- Endologix, Inc. announced that it has completed patient enrollment for the LUCY (Evaluation of FemaLes who are Underrepresented Candidates for Abdominal A…

German Registry Data Evaluated for Trends in Patient Safety of AAA Repair

February 7, 2017 -- German registry data on 36,594 procedures to repair nonruptured abdominal aortic aneurysms (AAA) were published by Matthias Trenner, MD, et al online …

Lombard Medical Launches IntelliFlex LP Delivery System in Japan

February 7, 2017 -- Lombard Medical, Inc. announced the Japanese launch of the IntelliFlex LP low-profile delivery system for the Aorfix endovascular stent graft for the treat…

Midterm Results Reported for Physician-Modified Endovascular Grafts to Treat Juxtarenal Aortic Aneurysms

February 1, 2017 -- In the Journal of Vascular Surgery (JVS), Benjamin W. Starnes, MD, et al published the midterm results from an ongoing physician-sponsored investigational …

CE Mark Reinstated for Endologix's AFX and AFX2 Endovascular AAA Systems

January 25, 2017 -- Endologix, Inc. announced that it has received notice from its Notified Body in the European Union that the CE Mark for the AFX and AFX2 end…

Three-Year Results Presented From Endologix's Ovation European Postmarket Registry

January 25, 2017 -- Endologix, Inc. announced the presentation of 3-year clinical data from its Ovation European postmarket registry by Patrick Peeters, MD, at LINC 2017,…

Terumo to Acquire Bolton Medical

January 19, 2017 -- Terumo Corporation announced a definitive agreement to acquire Bolton Medical, Inc. from its parent company. Bolton Medical develops, manufacture…

Study in The Netherlands Evaluates Risks of EVAR in Large-Diameter Necks

January 18, 2017 -- In order to determine the impact of infrarenal neck diameter on midterm outcomes following endovascular aneurysm repair (EVAR) with a single stent graft wi…

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.